Yang Rick

CIK 00018513286 companiesMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001851328

Recent Transactions

50 trades

Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,619,240→ 1,619,240 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series D Preferred Stock
2026-02-09−737,962→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series C-2 Preferred Stock
2026-02-09−1,370,168→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series C-1 Preferred Stock
2026-02-09−1,370,168→ 0 total
Conversion
SpyGlass Pharma, Inc.$SGP
Series B Preferred Stock
2026-02-09−1,619,240→ 0 total
Purchase
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09$16.00/sh+937,500→ 6,035,038 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+737,962→ 5,097,538 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,370,168→ 4,359,576 total
Conversion
SpyGlass Pharma, Inc.$SGP
Common Stock
2026-02-09+1,370,168→ 2,989,408 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−100,000→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+124,085→ 2,385,055 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−182→ 2,384,873 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−189,195→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series A Convertible Perpetual Preferred Stock
2025-10-02−125,000→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+1,656,789→ 1,656,789 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−2,455→ 1,654,334 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−900→ 2,260,970 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−2,384,873→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−186,128→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−37,700→ 0 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+124,085→ 124,085 total
Sale
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−280→ 488,702 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+186,128→ 674,830 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−674,554→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+607,536→ 2,261,870 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$0.01/sh+189,195→ 488,982 total
Tax Payment
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02$6.75/sh−276→ 674,554 total
Award
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02+186,128→ 186,128 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series A Convertible Perpetual Preferred Stock
2025-10-02−75,000→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−1,656,789→ 0 total
Exercise of In-Money
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−607,536→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2025-10-02−124,085→ 0 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+185,595→ 556,782 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-10-01+61,865→ 185,594 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+1,023,103→ 1,023,103 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16$16.00/sh+500,000→ 3,614,486 total
Conversion
MBX Biosciences, Inc.$MBX
Series B Convertible Preferred Stock
2024-09-16−25,142,840→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Series A Convertible Preferred Stock
2024-09-16−12,299,854→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+2,091,383→ 3,114,486 total
Purchase
Korro Bio, Inc.$KRRO
Common Stock
2024-04-22$56.00/sh+17,857→ 1,090,793 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-04-08+123,729→ 123,729 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2024-04-08+371,187→ 371,187 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2023-12-19+175,525→ 1,656,789 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2023-10-31+100,606→ 1,481,264 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2023-09-15+552,263→ 1,380,658 total
Purchase
NeueHealth, Inc.$NEUE
Warrant (Right to Buy)
2023-08-11+828,395→ 828,395 total
Purchase
Savara Inc$SVRA
Common Stock
2023-07-17$3.00/sh+333,333→ 24,471,264 total
Purchase
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2022-10-17$1000.00/sh+37,700→ 37,700 total
Purchase
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2022-10-17$1000.00/sh+100,000→ 100,000 total
Conversion
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2021-06-28+2,715,968→ 2,715,968 total

Companies

Recent Filings

Address

2855 SAND HILL ROAD

MENLO PARK, CA, 94025

View on SEC.gov